Home » Menachem Shoham, PhD, Co-founder and CSO » Menachem Shoham, PhD, Co-founder and CSO Menachem Shoham, PhD, Co-founder and CSO About the Author View all posts by iykkv Q2 Pharma is developing small-molecule antivirulence agents against bacterial infections. Leave a Reply Click here to cancel reply.
